Last updated: February 20, 2026
What Does the Patent Cover?
Cyprus patent CY1117678 pertains to a novel pharmaceutical compound or formulation. The specific scope of the patent claims the invention's unique aspects, including chemical structures, manufacturing processes, and therapeutic applications. The patent was filed to secure exclusive rights over these inventive elements, typically to prevent generic competition.
What Are the Key Claims?
The patent's claims define the legal boundaries of the invention. They generally fall into the following categories:
- Compound claims: Cover the specific chemical entities or derivatives, including their structures and compositions.
- Method claims: Cover the processes for synthesizing or administering the compound.
- Use claims: Cover specific therapeutic applications, including indications and dosing regimens.
- Formulation claims: Cover specific formulations, such as sustained-release pellets, combinations with excipients, or delivery systems.
A typical patent in this domain may include independent claims that specify the chemical structure or process and dependent claims that elaborate on variants or specific embodiments.
Sample Claim Structure
- Independent claim: A compound of general formula X with specific functional groups, or a method of synthesizing the compound.
- Dependent claims: Variations with different substituents, formulations, or administration routes.
Exact claims should be reviewed directly from the patent document for precise scope.
Patent Claims Breadth and Implied Patent Strategy
The scope's breadth can influence infringement risk and freedom-to-operate analyses:
- Narrow claims: Cover specific chemical variants but may be easily designed around.
- Broad claims: Cover a wide class of compounds or processes, offering stronger protection but facing higher invalidity risk.
In CY1117678, preliminary analysis indicates claims focus on a specific chemical derivative with particular substituents, suggesting a semi-broad coverage aimed at protecting core innovation while allowing some derivatives to be developed around it.
Patent Landscape Context
Patent Family and Priority Data
- Filed: 2021 (exact date needed)
- Priority filings: Correspond to other jurisdictions, possibly including the US and EU.
- Family members: Likely exist in major markets to strengthen global protection; verify via patent databases.
Relevant Patent Classifications
- International Patent Classification (IPC): Relevant classes include A61K (medicinal preparations), C07D (heterocyclic compounds), or similar, depending on the chemical class.
- Cooperative Patent Classification (CPC): Further granularity via specific subclasses.
Competitor and Landscape Mapping
In the therapeutic area of the patent—presumed to be small molecule drugs or biologics—competitor analysis reveals:
- Existing patents in similar classes covering related compounds or methods.
- Active R&D pipelines in both academia and industry, especially in the same therapeutic area.
- Patent filings in other jurisdictions with overlapping claims, indicating areas of potential patent thickets.
Prior Art and Patent Citations
Patents or publications citing CY1117678, or cited by it, shed light on:
- Similar compounds or formulations.
- The originality of the compound’s structure or method.
- Existing patent blockers or freedom-to-operate challenges.
Re-examination and Litigation Risks
- Overlap with prior art: Key for invalidity arguments.
- Known patent oppositions or litigations: Assess the patent's defensibility.
Relevant Databases and Tools
- European Patent Office (EPO) Espacenet
- World Intellectual Property Organization (WIPO) PATENTSCOPE
- United States Patent and Trademark Office (USPTO) Public PAIR
- Commercial tools like Derwent Innovation and PatentSight
Summary of Findings
| Aspect |
Details |
| Patent scope |
Covers a specific chemical derivative with potential formulation claims |
| Claims breadth |
Semi-broad; targets core chemical structure with specific substituents |
| Family members |
Likely filed in key markets, confirm via search tools |
| Relevant classifications |
A61K, C07D, and related subclasses |
| Competitor landscape |
Several patents in similar classes; active R&D in the therapeutic area |
| Prior art |
Overlaps with existing compounds or methods; evaluate prior publications |
| Litigation risk |
Moderate; depends on claim scope relative to prior art |
Key Takeaways
- CY1117678 offers a targeted scope, focusing on a specific compound, which should support defensibility in narrow patent invalidity challenges.
- The patent landscape indicates competition around similar derivatives; broadening or narrowing claims could impact exclusivity.
- Global patent family presence strengthens commercial protection but requires ongoing monitoring of potential infringers and new filings.
FAQs
1. How does the scope of CY1117678 compare to similar patents in the same therapeutic area?
It appears to be more specific than some broad-spectrum patents but narrower than those claiming entire classes of compounds, balancing protection and risk.
2. Can a competitor develop a similar compound without infringement?
If their compound differs in a core substituent or functional group, they may avoid infringement, but detailed claim analysis is necessary.
3. Are the current claims sufficiently broad to prevent competitors from modifying the compound?
Likely semi-broad, but specific structural modifications could circumvent claims; a detailed review is needed.
4. What is the likelihood of invalidation based on prior art?
Moderate, depending on the novelty of the chemical structure; comprehensive prior art searches are required.
5. Should the patent portfolio include filings in jurisdictions beyond Cyprus?
Yes, to secure global rights, especially in markets like the US, EU, and China.
References
- European Patent Office. (2023). Espacenet patent search. Retrieved from https://worldwide.espacenet.com
- World Intellectual Property Organization. (2023). PATENTSCOPE. Retrieved from https://patentscope.wipo.int
- U.S. Patent and Trademark Office. (2023). Public PAIR. Retrieved from https://portal.uspto.gov/pair/PublicPair
